We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Automated ELISA-IFA-BLOT Processor AP 22
Gold Supplier
SARS-COV-2 PLUS UK Real Time PCR kit
Gold Supplier
Influenza Type A & B Test
Influenza A+B DUO
Gold Supplier
pHOx Analyzer
BioProfile pHOx Analyzer
Visit expo >

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Image: The VersaMax ELISA Microplate Reader for visible absorbance measurements between 340 nm and 850 nm (Photo courtesy of Molecular Devices).

Biomarkers of Collagen Turnover Investigated in Crohn’s Disease

Crohn's disease (CD) is a chronic ulcerative inflammatory disease mainly affecting the gastrointestinal (GI) tract and is characterized by an inappropriate and uncontrolled immune response that is putatively triggered by the gut microbiome in genetically susceptible individuals. More...
24 Jun 2022
Image: A new method reliably detects protein changes in blood that are typical of Parkinson`s disease (Photo courtesy of Pexels)

First-Ever Blood Test Detects Parkinson’s Disease

To date, there have been neither blood parameters nor imaging examinations to produce a definite diagnosis of Parkinson's disease, let alone early recognition. Now, researchers have developed a method that reliably detects protein changes in blood that are typical of Parkinson's disease. More...
24 Jun 2022
Image: Automated liquid biopsy test quickly IDs cancer DNA in patients with metastatic breast cancer (Photo courtesy of Johns Hopkins)

Automated Liquid Biopsy Test Detects Advanced Breast Cancer in Five Hours

A novel, automated liquid biopsy test in development can accurately detect the presence of cancer DNA in the blood of patients with metastatic breast cancer within five hours. More...
24 Jun 2022
Image: Fujirebio has acquired ADx NeuroSciences for 40 million Euros (Photo courtesy of Pexels)

Fujirebio Acquires ADx NeuroSciences to Speed Development of Neurodegenerative Diseases Diagnostic Tests

Fujirebio Holdings, Inc. (Tokyo, Japan) has announced the acquisition of ADx NeuroSciences (Gent, Belgium) for EUR 40 million in a deal that is expected to close in July 2022, pending the satisfaction of customary closing conditions. More...
24 Jun 2022
Image: The Unyvero LRT Panel for Use with Bronchoalveolar Lavage Specimens (Photo courtesy of Rick Betts)

Pneumonia Panel Helps Curb Inappropriate Antibiotic Usage

Pneumonia is swelling (inflammation) of the tissue in one or both lungs. It's usually caused by a bacterial infection or a virus. The symptoms of pneumonia can develop suddenly over 24 to 48 hours, or they may come on more slowly over several days. More...
23 Jun 2022
Image: Colonic biopsy with features of collagenous colitis. Trichrome stain highlights irregular subepithelial collagen with entrapment of capillaries and inflammatory cells (Photo courtesy of Catherine E. Hagen, MD)

Appendectomy Linked to Higher Risk of Microscopic Colitis

The most common symptom of microscopic colitis is chronic, watery, non-bloody diarrhea. Episodes of diarrhea can last for weeks, months, or even years. However, many people with microscopic colitis may have long periods without diarrhea. More...
23 Jun 2022
Image: Stages of progression of non-alcoholic fatty liver disease (Photo courtesy of Wikimedia Commons)

Blood Test Predicts Likelihood that Nonalcoholic Fatty Liver Disease Will Progress to Liver Cancer

A bioinformatics approach was used to transform a 133-gene panel, which could predict the likelihood of a patient with nonalcoholic fatty liver disease (NAFLD) progressing to hepatocellular carcinoma (HCC), into an easily performed four-protein blood test. More...
23 Jun 2022
Copyright © 2000-2022 Globetech Media. All rights reserved.